| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 149,9 k € | -16.1% | 178,7 k € | -36.5% | 281,5 k € | -33.6% | 424,1 k € | +93.6% | 219,0 k € | +91.8% | 114,2 k € | -12.1% | 129,9 k € | +237.2% | 38,5 k € | +93.0% | 20,0 k € | +82.8% | 10,9 k € | +1744.1% | -664,2 € | +69.8% | -2,2 k € | -59.0% | -1,4 k € | -1.2% | -1,4 k € | +33.9% | -2,1 k € | -113.2% | -967,9 € | +6.3% | -1,0 k € | -37.5% | -750,9 € | +17.1% | -905,5 € | |
| EBITDA | 128,4 k € | -18.3% | 157,2 k € | -40.2% | 263,0 k € | -31.5% | 383,7 k € | +100.1% | 191,8 k € | +77.6% | 107,9 k € | -16.4% | 129,1 k € | +239.3% | 38,0 k € | +95.2% | 19,5 k € | +86.6% | 10,4 k € | +1425.5% | -788,2 € | +72.0% | -2,8 k € | -52.6% | -1,8 k € | -35.4% | -1,4 k € | +37.3% | -2,2 k € | -52.5% | -1,4 k € | +19.7% | -1,8 k € | -47.6% | -1,2 k € | -33.0% | -905,5 € | |
| Operating profit | 96,6 k € | -5.8% | 102,6 k € | -60.1% | 257,1 k € | -18.6% | 315,9 k € | +64.8% | 191,8 k € | +77.6% | 107,9 k € | -16.4% | 129,1 k € | +239.3% | 38,0 k € | +95.2% | 19,5 k € | +86.6% | 10,4 k € | +1425.5% | -788,2 € | +72.0% | -2,8 k € | -52.6% | -1,8 k € | -35.4% | -1,4 k € | +37.3% | -2,2 k € | -52.5% | -1,4 k € | +19.7% | -1,8 k € | -47.6% | -1,2 k € | -33.0% | -905,5 € | |
| Profit/loss | 109,3 k € | +56.2% | 69,9 k € | -57.9% | 166,3 k € | -32.7% | 247,0 k € | +59.7% | 154,6 k € | +103.9% | 75,8 k € | -16.1% | 90,4 k € | +264.2% | 24,8 k € | +42.1% | 17,5 k € | +68.7% | 10,4 k € | +3454.9% | -308,7 € | +89.0% | -2,8 k € | -52.6% | -1,8 k € | -35.4% | -1,4 k € | +37.3% | -2,2 k € | +1.6% | -2,2 k € | -38.4% | -1,6 k € | -20.5% | -1,3 k € | -31.5% | -1,0 k € | |
| Equity | 935,4 k € | +13.2% | 826,2 k € | +9.2% | 756,2 k € | +28.2% | 589,9 k € | +59.7% | 369,4 k € | +54.1% | 239,8 k € | +46.3% | 163,9 k € | +122.8% | 73,6 k € | +50.9% | 48,8 k € | +55.8% | 31,3 k € | +49.5% | 20,9 k € | -1.5% | 21,2 k € | -11.7% | 24,1 k € | -7.1% | 25,9 k € | -5.0% | 27,3 k € | -7.4% | 29,4 k € | -7.0% | 31,7 k € | -4.8% | 33,2 k € | -3.8% | 34,6 k € | |
| Total assets | 1,8 M € | +7.9% | 1,7 M € | -0.4% | 1,7 M € | +8.9% | 1,6 M € | +224.2% | 482,8 k € | +53.9% | 313,8 k € | +30.2% | 241,1 k € | +106.1% | 117,0 k € | +105.4% | 57,0 k € | +65.5% | 34,4 k € | +54.5% | 22,3 k € | -5.8% | 23,7 k € | -9.6% | 26,2 k € | -7.1% | 28,1 k € | -4.9% | 29,6 k € | -7.1% | 31,8 k € | -7.8% | 34,5 k € | -2.8% | 35,5 k € | -3.4% | 36,8 k € | |
| Cash | 151,1 k € | +3457.8% | 4,2 k € | -79.9% | 21,2 k € | -87.4% | 168,0 k € | +876.3% | 17,2 k € | +4701.6% | 358,5 € | -85.1% | 2,4 k € | -79.8% | 11,9 k € | -65.9% | 34,9 k € | +181.9% | 12,4 k € | +17150.8% | 71,8 € | — | — | — | — | — | — | — | 33,9 € | |||||||||
| Debts | 897,0 k € | +2.9% | 871,4 k € | -8.1% | 948,8 k € | +1.3% | 936,3 k € | +980.8% | 86,6 k € | +27.6% | 67,9 k € | -12.0% | 77,1 k € | +77.6% | 43,4 k € | +429.1% | 8,2 k € | +161.6% | 3,1 k € | +133.0% | 1,3 k € | -44.3% | 2,4 k € | +14.8% | 2,1 k € | -6.4% | 2,2 k € | -3.1% | 2,3 k € | -3.0% | 2,4 k € | -17.3% | 2,9 k € | +26.3% | 2,3 k € | +3.6% | 2,2 k € | |
| Staff | 0,2 | 0,2 | 0,2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||
Private limited company profitable and well capitalised. Cash position rising (+3457.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
GREEN 2 is a Private limited company incorporated in 1997. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Oostende. It employs on average 0,2 ETP workers (FTE).
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette